Revance Therapeutics Inc (RVNC)
3.69
+0.29
(+8.53%)
USD |
NASDAQ |
Apr 29, 16:00
3.69
0.00 (0.00%)
After-Hours: 20:00
Revance Therapeutics Price: 3.69 for April 29, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 29, 2024 | 3.45 | 3.77 | 3.41 | 3.69 | 3.224M |
Apr 26, 2024 | 3.36 | 3.56 | 3.21 | 3.40 | 2.280M |
Apr 25, 2024 | 3.50 | 3.50 | 3.23 | 3.29 | 2.647M |
Apr 24, 2024 | 3.64 | 3.75 | 3.539 | 3.57 | 1.789M |
Apr 23, 2024 | 3.64 | 3.81 | 3.62 | 3.66 | 1.589M |
Apr 22, 2024 | 3.83 | 3.87 | 3.61 | 3.64 | 1.813M |
Apr 19, 2024 | 3.80 | 3.87 | 3.71 | 3.78 | 1.648M |
Apr 18, 2024 | 3.75 | 3.82 | 3.625 | 3.79 | 1.598M |
Apr 17, 2024 | 3.87 | 3.90 | 3.74 | 3.76 | 1.740M |
Apr 16, 2024 | 3.97 | 3.97 | 3.72 | 3.81 | 2.419M |
Apr 15, 2024 | 4.08 | 4.19 | 3.96 | 3.97 | 2.122M |
Apr 12, 2024 | 4.39 | 4.45 | 4.10 | 4.13 | 1.578M |
Apr 11, 2024 | 4.45 | 4.53 | 4.21 | 4.44 | 1.882M |
Apr 10, 2024 | 4.47 | 4.575 | 4.31 | 4.41 | 1.591M |
Apr 09, 2024 | 4.49 | 4.94 | 4.47 | 4.69 | 1.775M |
Apr 08, 2024 | 4.38 | 4.470 | 4.355 | 4.45 | 833494.0 |
Apr 05, 2024 | 4.37 | 4.47 | 4.33 | 4.41 | 1.263M |
Apr 04, 2024 | 4.65 | 4.70 | 4.36 | 4.41 | 1.057M |
Apr 03, 2024 | 4.52 | 4.64 | 4.37 | 4.55 | 1.334M |
Apr 02, 2024 | 4.61 | 4.63 | 4.45 | 4.51 | 1.722M |
Apr 01, 2024 | 4.99 | 4.99 | 4.66 | 4.73 | 1.142M |
Mar 28, 2024 | 5.00 | 5.03 | 4.855 | 4.92 | 1.245M |
Mar 27, 2024 | 4.78 | 4.955 | 4.68 | 4.94 | 1.569M |
Mar 26, 2024 | 4.70 | 4.90 | 4.63 | 4.70 | 1.109M |
Mar 25, 2024 | 4.92 | 5.020 | 4.57 | 4.65 | 1.448M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.29
Minimum
Apr 25 2024
37.61
Maximum
May 09 2023
20.03
Average
20.30
Median
Nov 09 2022
Price Benchmarks
AbbVie Inc | 161.52 |
Alnylam Pharmaceuticals Inc | 147.36 |
Ionis Pharmaceuticals Inc | 41.99 |
Madrigal Pharmaceuticals Inc | 201.07 |
Vertex Pharmaceuticals Inc | 396.20 |
Price Related Metrics
PS Ratio | 1.334 |
Earnings Yield | -103.0% |
Market Cap | 384.55M |